HS Icon Special Pharmaceuticals in  Flag United States

2020
Exports | Imports
: $1.63B | $2.5B, World Rnk 2 / 177
Flag Rnk 151 / 1217 | World Rnk 1 / 222
Flag Rnk 163 / 1214

2019 - 2020
FASTEST GROWING MARKET | FASTEST GROWING ORIGIN
: $8.72M | $94.1M, China |  Italy

2020
ECONOMIC COMPLEXITY of United States
: 1.56, Rnk 9 / 127

2020
PRODUCT COMPLEXITY  IN Special Pharmaceuticals
: 0.58, Rnk 328 / 1029

Exports In 2020, United States exported $1.63B in Special Pharmaceuticals, making it the 2nd largest exporter of Special Pharmaceuticals in the world. At the same year, Special Pharmaceuticals was the 151st most exported product in United States. The main destination of Special Pharmaceuticals exports from United States are: Japan ($249M), China ($206M), Belgium ($199M), Singapore ($194M), and Canada ($105M).

The fastest growing export markets for Special Pharmaceuticals of United States between 2019 and 2020 were China ($8.72M), Afghanistan ($7.9M), and Kuwait ($5.57M).

Imports In 2020, United States imported $2.5B in Special Pharmaceuticals, becoming the 1st largest importer of Special Pharmaceuticals in the world. At the same year, Special Pharmaceuticals was the 163rd most imported product in United States. United States imports Special Pharmaceuticals primarily from: Finland ($509M), Germany ($277M), Switzerland ($226M), Italy ($220M), and Canada ($181M).

The fastest growing import markets in Special Pharmaceuticals for United States between 2019 and 2020 were Italy ($94.1M), Belgium ($79.7M), and Netherlands ($64.4M).

Tariffs In 2018, the average tariff for United States in Special Pharmaceuticals was 0.62%. The countries with the highest import tariffs for Special Pharmaceuticals were North Korea (Most Favoured Nation duty rate treatement, 1.15%), Cuba (Most Favoured Nation duty rate treatement, 1.15%), Algeria (Most Favoured Nation duty rate treatement, 0.92%), Egypt (Most Favoured Nation duty rate treatement, 0.92%), and Eritrea (Most Favoured Nation duty rate treatement, 0.92%).

November 2022

Subnational Monthly Trade

#permalink to section
Time Scale
Flow
Value

EXPORT GROWTH (November 2021 - November 2022): $33.7M, (21.5%)

IMPORT GROWTH (November 2021 - November 2022): $14.8M, (4.22%)

MAIN EXPORTER (November 2022): Tennessee, $60.3M

MAIN DESTINATION (November 2022): China, $30.3M

This section shows Special Pharmaceuticals's exports and imports data at subnational level for United States. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Special Pharmaceuticals over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Historical Data

#permalink to section
Value
Compare to

EXPORTS (2020): $1.63B

IMPORTS (2020): $2.5B

NET TRADE (2020): -$865M

In 2020, United States exported $1.63B in Special Pharmaceuticals. The main destinations of United States exports on Special Pharmaceuticals were Japan ($249M), China ($206M), Belgium ($199M), Singapore ($194M), and Canada ($105M).

In 2020, United States imported $2.5B in Special Pharmaceuticals, mainly from Finland ($509M), Germany ($277M), Switzerland ($226M), Italy ($220M), and Canada ($181M).

Explore Visualizations

Flow

THE FASTEST GROWING Special Pharmaceuticals EXPORT MARKETS FOR United States WERE (2019 - 2020):

THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Special Pharmaceuticals BY United States WERE (2019 - 2020):

Explore Visualizations

Market Concentration

#permalink to section
View
Flow
Type

In 2020, United States's main exporting competitors in Special Pharmaceuticals were:

In 2020, United States's main importing competitors in Special Pharmaceuticals were:

Explore Visualizations